Petra Sicher

Petra Sicher is a highly experienced professional in quality assurance and clinical research, currently serving as Quality Expert and Head of GCP Audits and Inspection at ObelysQ SA since June 2022. Prior to this role, Petra held various positions at Bristol Myers Squibb from 2016 to June 2022, including Associate Director Molecule Quality Lead Cellular Therapy and Senior GCP Auditor. Experience also encompasses significant roles at the European Thoracic Oncology Platform and International Breast Cancer Study Group, where Petra developed risk-based monitoring and audit strategies, conducted worldwide audits, managed SOPs, and ensured compliance with quality systems throughout clinical development. Petra's medical background includes roles as a Medical Doctor at Private Clinic Wyss and Canton Hospital Schaffhausen, along with a research fellowship in rheumatology at Inselspital Bern. Academic credentials include a Doctor of Medicine degree from the University of Berne.